These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A pretargeting system for tumor PET imaging and radioimmunotherapy. Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Frampas E; Faivre-Chauvet A; Rauscher A; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J Front Pharmacol; 2015; 6():54. PubMed ID: 25873896 [TBL] [Abstract][Full Text] [Related]
24. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. Goodwin DA; Meares CF; Osen M J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294 [TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420 [TBL] [Abstract][Full Text] [Related]
26. Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu. Mohsin H; Jia F; Bryan JN; Sivaguru G; Cutler CS; Ketring AR; Miller WH; Simón J; Frank RK; Theodore LJ; Axworthy DB; Jurisson SS; Lewis MR Bioconjug Chem; 2011 Dec; 22(12):2444-52. PubMed ID: 22053899 [TBL] [Abstract][Full Text] [Related]
27. Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers. Green DJ; Frayo SL; Lin Y; Hamlin DK; Fisher DR; Frost SH; Kenoyer AL; Hylarides MD; Gopal AK; Gooley TA; Orozco JJ; Till BG; O'Steen S; Orcutt KD; Wilbur DS; Wittrup KD; Press OW Cancer Res; 2016 Nov; 76(22):6669-6679. PubMed ID: 27590740 [TBL] [Abstract][Full Text] [Related]
28. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma. Hamblett KJ; Press OW; Meyer DL; Hamlin DK; Axworthy D; Wilbur DS; Stayton PS Bioconjug Chem; 2005; 16(1):131-8. PubMed ID: 15656584 [TBL] [Abstract][Full Text] [Related]
29. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361 [TBL] [Abstract][Full Text] [Related]
30. Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten. Gautherot E; Bouhou J; Le Doussal JM; Manetti C; Martin M; Rouvier E; Barbet J Cancer; 1997 Dec; 80(12 Suppl):2618-23. PubMed ID: 9406716 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. Kraeber-Bodéré F; Faivre-Chauvet A; Ferrer L; Vuillez JP; Brard PY; Rousseau C; Resche I; Devillers A; Laffont S; Bardiès M; Chang K; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3973S-81S. PubMed ID: 14506196 [TBL] [Abstract][Full Text] [Related]
32. Pretargeting with the affinity enhancement system for radioimmunotherapy. Barbet J; Kraeber-Bodéré F; Vuillez JP; Gautherot E; Rouvier E; Chatal JF Cancer Biother Radiopharm; 1999 Jun; 14(3):153-66. PubMed ID: 10850300 [TBL] [Abstract][Full Text] [Related]
34. Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles. Parker CL; Yang Q; Yang B; McCallen JD; Park SI; Lai SK Acta Biomater; 2017 Nov; 63():181-189. PubMed ID: 28870833 [TBL] [Abstract][Full Text] [Related]
35. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Janevik-Ivanovska E; Gautherot E; Hillairet de Boisferon M; Cohen M; Milhaud G; Tartar A; Rostene W; Barbet J; Gruaz-Guyon A Bioconjug Chem; 1997; 8(4):526-33. PubMed ID: 9258451 [TBL] [Abstract][Full Text] [Related]
36. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer. Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917 [TBL] [Abstract][Full Text] [Related]
37. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810 [TBL] [Abstract][Full Text] [Related]
38. Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry. van de Watering FC; Rijpkema M; Robillard M; Oyen WJ; Boerman OC Front Med (Lausanne); 2014; 1():44. PubMed ID: 25593917 [TBL] [Abstract][Full Text] [Related]